Log In Sign up
The largest database of trusted experimental protocols

Anti il 2 bv711

Manufactured by BD
Visit Supplier

Anti-IL-2 BV711 is a fluorescent-conjugated antibody that binds to the cytokine interleukin-2 (IL-2). It is designed for use in flow cytometry and other immunoassay applications to detect and quantify IL-2 expression.

Automatically generated - may contain errors

Lab products found in correlation

Anti cd4 apc cy7, by BD (3 mentions) Anti il 17f bv786, by BD (3 mentions) Anti tnf α buv395, by BD (3 mentions) Anti il 13 bv421, by BD (3 mentions) Anti il 17a apccy7, by BioLegend (3 mentions) Anti cd25 pe cy7, by BD (3 mentions) Anti il 9 percp cy5, by BD (2 mentions) Anti cd34 fitc, by BD (2 mentions) Anti ccr7 fitc, by R&D Systems (2 mentions) Apc anti cd10, by BD (2 mentions) Anti cd27 pe cy7, by BD (2 mentions) Anti cd27 pe, by BD (2 mentions) Anti igg apc, by BD (2 mentions) Anti cd3 bv421, by BD (2 mentions) Anti ifn γ bv605, by BD (2 mentions) Anti cd19 bv711, by BD (2 mentions) Anti ccr6 pe, by BD (2 mentions) Anti cd127 bv650, by BioLegend (2 mentions) Anti cd20 pacific blue, by BioLegend (2 mentions) Anti cxcr3 bv421, by BioLegend (2 mentions)

3 protocols using anti il 2 bv711

1

Comprehensive Immunophenotyping Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following were purchased from eBiosciences: anti-IL-21 eFluor660, anti-IL-10 Alexa Fluor 488, anti-IFNγ BV605, anti-CD45RA FITC, anti-ICOS PE, anti-PD-1 biotin. The following were purchased from Becton Dickinson: anti-CXCR5 Alexa Fluor 647, anti-CD4 APC-Cy7, anti-IL-2 BV711, anti-CD25 PE-Cy7, anti-CD127 PerCP-Cy5.5, SA-PerCpCy5.5, anti-IL-17F BV786, anti-TNFα BUV395, anti-IL-9 PerCP-Cy5.5, anti-IL-13 BV421. The following were purchased from Biolegend: anti-IL-22 PE, anti-IL-4 PE-Cy7, anti-IL-17A APC-Cy7. The TCR Vß repertoire kit was from Beckman Coulter. Recombinant human IL-12 was purchased from R&D Systems.
Bier J., Rao G., Payne K., Brigden H., French E., Pelham S.J., Lau A., Lenthall H., Edwards E.S., Smart J.M., Cole T.S., Choo S., Joshi A.Y., Abraham R.S., O’Sullivan M., Boztug K., Meyts I., Gray P.E., Berglund L.J., Hsu P., Wong M., Holland S.M., Notarangelo L.D., Uzel G., Ma C.S., Brink R., Tangye S.G, & Deenick E.K. (2019). Activating mutations in PIK3CD and murine CD4+ T cells. The Journal of allergy and clinical immunology, 144(1), 236-253.
+ Open protocol
+ Expand
2

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following mAbs were used: anti-CD20 BUV395, anti-CD10 APC, anti-CD4 BUV737, anti-CD4 APCCy7, anti-CD25 PECy7, anti-CD27 PECy7, anti-CD27 PE, anti-CD45RA BV605, anti-CXCR5 A647, anti-IgG APC, anti-IgG PE, anti-IgG BV605, anti-CD8 BUV395, anti-PD1 BV605, Streptavidin-PerCPCy5.5, anti-IgM PerCPCy5.5, anti-CD3 BV421, anti-IL-2 BV711, anti-IL-9 PerCPCy5.5, anti-IL-13 BV421, anti-IL-17F BV786, anti-IFN-γ BV605, anti-TNF-α BUV395, anti-CD19 BV711, anti-CD34 FITC, anti-CCR6 PE (all from Becton Dickinson); anti-CCR7 PECy7, anti-CD127 BV650, anti-IL-17A APCCy7, anti-CD20 Pacific Blue, anti-FoxP3 PE, anti-CXCR3 BV421 (BioLegend); anti-CD45RA PerCPCy5.5 (eBioscience); anti-CCR7 FITC (R&D Systems); anti-IgA-biotin (SouthernBiotech); anti-IL-4 PECy7, anti-IL-21 e660, anti-IL-22 PE (Thermo Fisher Scientific).
Nguyen T., Lau A., Bier J., Cooke K.C., Lenthall H., Ruiz-Diaz S., Avery D.T., Brigden H., Zahra D., Sewell W.A., Droney L., Okada S., Asano T., Abolhassani H., Chavoshzadeh Z., Abraham R.S., Rajapakse N., Klee E.W., Church J.A., Williams A., Wong M., Burkhart C., Uzel G., Croucher D.R., James D.E., Ma C.S., Brink R., Tangye S.G, & Deenick E.K. (2023). Human PIK3R1 mutations disrupt lymphocyte differentiation to cause activated PI3Kδ syndrome 2. The Journal of Experimental Medicine, 220(6), e20221020.
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry of PBMC Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cryopreserved PBMCs and their subpopulations were analysed with a 28-color flow cytometry panel, as previously described [34 (link)]. The following mAbs were used: anti-CD20 BUV805, anti-CD10 APC, anti-Vαβ TCR BUV737, anti-CD4 APCCy7, anti-CD25 PECy7, anti-CD27 PECy7, anti-CD27 PE, anti-CD45RA PerCpCy5, anti- CXCR5 BUV615, anti-IgG APC, anti IgG BB660, anti-IgD BV480, anti-IgG BV605, anti-IgA1/A2 PECy5, anti-CD8 BUV496, anti-CD21 BUV563, anti-PD1 BV605, anti-IgM PerCPCy5.5, anti-IgM APC R700, anti-CD3 BV421, anti-IL-2 BV711, anti-IL-9 PerCPCy5.5, anti-IL-13 BV421, anti-IL-17F BV786, anti-IFN-γ BV605, anti-TNF-α BUV395, anti-CD19 BV711, anti-CD34 FITC, anti-CCR6 PE, anti-CD45RA BUV395, anti-CXCR5 BV615 (all from Becton Dickinson); anti-CD20 Pacific Blue, anti-CCR7 PECy7, anti-CD127 BV650, anti-IL-17A APCCy7, anti-CD20 BUV805, anti-CXCR3 BV421, anti-CD3 BV570 (BioLegend); (OptiBuild); anti-CCR7 FITC (R&D Systems); anti-IL-4 PECy7, anti-IL-21 e660, anti-IL-22 PE (Thermo Fisher Scientific).
Mina E.D., Jackson K.J., Crawford A.J., Faulks M.L., Pathmanandavel K., Acquarola N., O’Sullivan M., Kerre T., Naesens L., Claes K., Goodnow C.C., Haerynck F., Kracker S., Meyts I., D’Orsogna L.J., Ma C.S, & Tangye S.G. (2024). A Novel Heterozygous Variant in AICDA Impairs Ig Class Switching and Somatic Hypermutation in Human B Cells and is Associated with Autosomal Dominant HIGM2 Syndrome. Journal of Clinical Immunology, 44(3), 66.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!